Leonessa F - Search Results

1

The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.

Leonessa F, Boulay V, Wright A, Thompson EW, Brünner N, Clarke R. Leonessa F, et al. Acta Oncol. 1992;31(2):115-23. doi: 10.3109/02841869209088890. Acta Oncol. 1992. PMID: 1622625 Review.

2

Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.

Clarke R, Skaar T, Baumann K, Leonessa F, James M, Lippman J, Thompson EW, Freter C, Brunner N. Clarke R, et al. Among authors: leonessa f. Breast Cancer Res Treat. 1994;31(2-3):237-48. doi: 10.1007/BF00666157. Breast Cancer Res Treat. 1994. PMID: 7881102 Review.

3

Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL, Brünner N. Clarke R, et al. Among authors: leonessa f. Breast Cancer Res Treat. 1993;24(3):227-39. doi: 10.1007/BF01833263. Breast Cancer Res Treat. 1993. PMID: 8435478 Review.

4

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).

Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brünner N, Wang Y, Clarke R. Gu Z, et al. Among authors: leonessa f. Cancer Res. 2002 Jun 15;62(12):3428-37. Cancer Res. 2002. PMID: 12067985

5

Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis.

Clarke R, Leonessa F, Trock B. Clarke R, et al. Among authors: leonessa f. Semin Oncol. 2005 Dec;32(6 Suppl 7):S9-15. doi: 10.1053/j.seminoncol.2005.09.009. Semin Oncol. 2005. PMID: 16360717 Review.

6

Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.

Leonessa F, Jacobson M, Boyle B, Lippman J, McGarvey M, Clarke R. Leonessa F, et al. Cancer Res. 1994 Jan 15;54(2):441-7. Cancer Res. 1994. PMID: 7903910

7

MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.

Leonessa F, Green D, Licht T, Wright A, Wingate-Legette K, Lippman J, Gottesman MM, Clarke R. Leonessa F, et al. Br J Cancer. 1996 Jan;73(2):154-61. doi: 10.1038/bjc.1996.29. Br J Cancer. 1996. PMID: 8546900 Free PMC article.

8

Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms.

Clarke R, Skaar T, Leonessa F, Brankin B, James M, Brünner N, Lippman ME. Clarke R, et al. Among authors: leonessa f. Cancer Treat Res. 1996;87:263-83. doi: 10.1007/978-1-4613-1267-3_11. Cancer Treat Res. 1996. PMID: 8886457 Review. No abstract available.

9

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

Trock BJ, Leonessa F, Clarke R. Trock BJ, et al. Among authors: leonessa f. J Natl Cancer Inst. 1997 Jul 2;89(13):917-31. doi: 10.1093/jnci/89.13.917. J Natl Cancer Inst. 1997. PMID: 9214671

10

Cellular and molecular pharmacology of antiestrogen action and resistance.

Clarke R, Leonessa F, Welch JN, Skaar TC. Clarke R, et al. Among authors: leonessa f. Pharmacol Rev. 2001 Mar;53(1):25-71. Pharmacol Rev. 2001. PMID: 11171938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters